Article open access publication

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria

Diabetes Care, American Diabetes Association, ISSN 1066-9442

Volume 41, 7, 2018

DOI:10.2337/dc17-2392, Dimensions: pub.1103218729, PMID: 29643059,

Affiliations

Organisations

  1. (1) Nordic Bioscience (Denmark), grid.436559.8
  2. (2) University of Southern Denmark, grid.10825.3e, SDU
  3. (3) Steno Diabetes Center, grid.419658.7, Capital Region
  4. (4) Technical University of Denmark, grid.5170.3, DTU
  5. (5) Rigshospitalet, grid.475435.4, Capital Region
  6. (6) Odense University Hospital, grid.7143.1, Southern Denmark Region
  7. (7) University of Copenhagen, grid.5254.6, KU

Countries

Denmark

Continents

Europe

Description

OBJECTIVE: Type 2 diabetes is a common risk factor for the development of chronic kidney disease (CKD). Enhanced de novo collagen type VI (COL VI) formation has been associated with renal fibrosis and CKD. We investigated the hypothesis that PRO-C6, a product specifically generated during COL VI formation, is prognostic for adverse outcomes in patients with type 2 diabetes and microalbuminuria. RESEARCH DESIGN AND METHODS: In a prospective, observational study, we measured PRO-C6 in the serum (S-PRO-C6) and urine (U-PRO-C6) of 198 patients with type 2 diabetes and microalbuminuria without symptoms of coronary artery disease. Patients were followed for a median of 6.5 years, and end points were a composite of cardiovascular events (n = 38), all-cause mortality (n = 26), and reduction of estimated glomerular filtration rate (eGFR) of >30% (disease progression [n = 42]). Cox models were unadjusted and adjusted for the conventional risk factors of sex, age, BMI, systolic blood pressure, LDL cholesterol, smoking, HbA1c, plasma creatinine, and urinary albumin excretion rate. RESULTS: Doubling of S-PRO-C6 increased hazards for cardiovascular events (hazard ratio 3.06 [95% CI 1.31-7.14]), all-cause mortality (6.91 [2.96-16.11]), and disease progression (4.81 [1.92-12.01]). Addition of S-PRO-C6 to a model containing conventional risk factors improved relative integrated discrimination by 22.5% for cardiovascular events (P = 0.02), 76.8% for all-cause mortality (P = 0.002), and 53.3% for disease progression (P = 0.004). U-PRO-C6 was not significantly associated with any of the outcomes. CONCLUSIONS: S-PRO-C6 generated during COL VI formation predicts cardiovascular events, all-cause mortality, and disease progression in patients with type 2 diabetes and microalbuminuria.

Funders

Research Categories

Main Subject Area

Fields of Research

Links & Metrics

NORA University Profiles

University of Southern Denmark

Technical University of Denmark

University of Copenhagen

Dimensions Citation Indicators

Times Cited: 14

Field Citation Ratio (FCR): 10.83

Relative Citation ratio (RCR): 1.36

Open Access Info

Bronze